Factors Associated with the Steep Increase in Late Midlife Stroke Occurrence among US Men

Journal of Stroke and Cerebrovascular Diseases

Volumn 17, Issue 4, 2008, Pages 165-168

  Towfighi, Amytis ^a   Saver, Jeffrey L ^a   Engelhardt, Rita ^b   Ovbiagele, Bruce ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

Men; midlife; National Health and Nutrition Examination Survey; risk factors; stroke

Indexed keywords

HOMOCYSTEINE;

ADULT; AGING; ANKLE BRACHIAL INDEX; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; STROKE; UNITED STATES;

ATHEROSCLEROSIS; ATRIAL FIBRILLATION; COMORBIDITY; CORONARY DISEASE; DIABETES MELLITUS; DYSLIPIDEMIAS; HEADACHE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERHOMOCYSTEINEMIA; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; NUTRITION SURVEYS; RISK FACTORS; STROKE; UNITED STATES;

EID: 45549110131     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2007.12.007     Document Type: Article

References (14)

1. Rosamond W., Flegal K., Friday G., et al. Heart disease and stroke statistics-2007 update: A report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation 115 (2007) e69-e171
2. Towfighi A., Saver J., Liebeskind D., et al. Does overall atherosclerotic burden contribute to late midlife acceleration of stroke in men?. Stroke 38 (2007) 533 (abstr)
3. Sacco R.L., Adams R., Albers G., et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: A statement for healthcare professionals from the American Heart Association/American Stroke Association council on stroke; co-sponsored by the Council on Cardiovascular Radiology and Intervention, the American Academy of Neurology affirms the value of this guideline. Stroke 37 (2006) 577-617
4. Goldstein L.B., Adams R., Alberts M.J., et al. Primary prevention of ischemic stroke: A guideline from the American Heart Association/American Stroke Association stroke council; cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group, the American Academy of Neurology affirms the value of this guideline. Stroke 37 (2006) 1583-1633
5. National Center for Health Statistics. National health and nutrition examination survey. Available from: URL:http://www.cdc.gov/nchs/nhanes.htm. Accessed January 1, 2007.
6. Virtanen J.K., Voutilainen S., Happonen P., et al. Serum homocysteine, folate and risk of stroke: Kuopio ischemic heart disease risk factor (KIHD) study. Eur J Cardiovasc Prev Rehabil 12 (2005) 369-375
7. Toole J.F., Malinow M.R., Chambless L.E., et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: The vitamin intervention for stroke prevention (VISP) randomized controlled trial. JAMA 291 (2004) 565-575
8. Bonaa K.H., Njolstad I., Ueland P.M., et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354 (2006) 1578-1588
9. Lonn E., Yusuf S., Arnold M.J., et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354 (2006) 1567-1577
10. Dusitanond P., Eikelboom J.W., Hankey G.J., et al. Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: A randomized substudy of the VITATOPS trial. Stroke 36 (2005) 144-146
11. Virtanen J.K., Voutilainen S., Alfthan G., et al. Homocysteine as a risk factor for CVD mortality in men with other CVD risk factors: The Kuopio ischemic heart disease risk factor (KIHD) study. J Intern Med 257 (2005) 255-262
12. Bos M.J., van Goor M.L., Koudstaal P.J., et al. Plasma homocysteine is a risk factor for recurrent vascular events in young patients with an ischemic stroke or TIA. J Neurol 252 (2005) 332-337
13. Spence J.D. Homocysteine-lowering therapy: A role in stroke prevention?. Lancet Neurol 6 (2007) 830-838
14. Engstad T., Bonaa K.H., and Viitanen M. Validity of self-reported stroke: The Tromso study. Stroke 31 (2000) 1602-1607